Results 111 to 120 of about 21,677 (267)

Retraction notice to “Comparison of the efficacy and side effects of Fixed-does combination of Aclidinium/Formoterol and Monotherapy of Aclidinium or Formoterol in COPD: A meta-analysis” [YMHL 51C (2022) 25–31] [PDF]

, 2022
Kaiwen Ni, Jia Yang, Huan Yang, Shiming Zhu, Zhen Wang   +4 more
openalex   +1 more source

COPD: Optimizing Treatment [PDF]

, 2015
A guideline update and an expanded armamentarium have many physicians wondering how best to treat patients with COPD. Chronic obstructive pulmonary disease (COPD) carries a high disease burden. In 2012, it was the 4th leading cause of death worldwide.1,2
Ahmed-Sarwar, Nabila, Holub, David C, Pierce, Deirdre P   +2 more
core   +1 more source

Effect of formoterol, a long-acting β₂-adrenergic agonist, on muscle strength and power output, metabolism, and fatigue during maximal sprinting in men [PDF]

, 2016
Anders Kalsen, Morten Hostrup, Vibeke Backer, Jens Bangsbo   +3 more
openalex   +1 more source

SIMVASTATIN INDUCED HISTOMORPHOLOGICAL CHANGES IN SKELETAL MUSCLE FIBER OF RATS AND PROTECTIVE EFFECT OF FORMOTEROL COADMINISTRATION

Pakistan Armed Forces Medical Journal, 2019
Objective: To study Simvastatin induced, qualitative histomorphological changes in skeletal muscle fibers of rats and find protective effect of Formoterol co-administration in Simvastatin induced myopathy.
Abdullah Qamar, Shoaib Naiyar Hashmi, Fareeha Mushtaq   +2 more
doaj  

Role of inhaled corticosteroids/formoterol in relieving acute asthma as compared to traditional salbutamol in children 6 to 11 years old on maintenance and reliever therapy step 3 and above as per the Global Initiative for Asthma guideline

Monaldi Archives for Chest Disease
The recent Global Initiative for Asthma (GINA) guidelines offer two reliever therapy options for patients on step 3 and above: the more popularly used short-acting β-agonists (SABA) and the newly introduced inhaled corticosteroids (ICS)-formoterol ...
Danish Abdul Aziz, Werdah Viquar
doaj   +1 more source

Avaliação da eficácia e segurança da associação de budesonida e formoterol em dose fixa e cápsula única no tratamento de asma não controlada: ensaio clínico randomizado, duplo-cego, multicêntrico e controlado [PDF]

, 2012
Roberto Stirbulov, Carlos Cézar Fritscher, Emílio Pizzichini, Márcia Margaret Menezes Pizzichini   +3 more
openalex   +1 more source

24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study [PDF]

, 2020
David A. Lipson, Ruby Birk, Noushin Brealey, Chang‐Qing Zhu   +3 more
openalex   +1 more source

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial [PDF]

, 2021
Klaus F. Rabe, Fernando J. Martínez, Dave Singh, Roopa Trivedi, Martin Jenkins, Patrick Darken, Magnus Aurivillius, Paul Dorinsky   +7 more
openalex   +1 more source

EFFECT OF LONG ACTING β2-AGONISTS ON GROSS MORPHOLOGY OF SKELETAL MUSCLES AND CREATINE PHOSPHOKINASE LEVEL IN SIMVASTATIN INDUCED MYOPATHIES IN RATS

Pakistan Armed Forces Medical Journal, 2019
Objective: To study the gross morphology of skeletal muscles and plasma Creatinine phosphokinase levels of rats and find effect of long acting β2-agonists co-administration in Statin induced myopathies. Study Design: Quasi experimental study. Place
Abdullah Qamar, Hina Kundi, Maria Yousaf, Sajid Ali   +3 more
doaj  

Tolerability of Budesonide (BUD)/Formoterol (FM) Pressurized Metered-Dose Inhaler (pMDI): Pooled Adverse Event (AE) Data From Clinical Studies of Children, Adolescents, and Adults With Asthma [PDF]

, 2008
Lanny J. Rosenwasser, Stefan Peters, Piet Vervaet, C. O’Brien   +3 more
openalex   +1 more source